Recent Advance in the Application of Bioprint and Biomaterials
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".
Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 7344
Special Issue Editors
Interests: 3D printing; biodegradable polymer; bioprinting; controlled drug release; tissue engineering
Interests: multi-material additive manufacturing; biomaterials; photoreactive formulations; inkjet based 3D printing
Special Issue Information
Dear Colleagues,
Artificial tissues and organs with similar functions and architecture to their biological counterpart are used for reducing medical testing costs, addressing problems in tissue placement and organ shortage in transplantation. Three-dimensional bioprinting, a state of the art technology, allows biomaterials, cells and growth factors to be integrated and patterned on demand. It is gaining overwhelming interest from clinicians and researchers due to its ability to fabricate highly sophisticated constructs. Three-dimensional bioprinting technologies are an extensible application of additive manufacturing technologies, including extrusion-based, projection-based, inkjet-based and laser-based printing techniques. The bioink, a combination of structure material, cells, growth factors and other components, is structured in a layer-by-layer manner into desired geometries or devices. The recent application of bioprinting includes scaffolds or scaffolds-free constructs, organs, tissues, organ-on-a-chip, etc. This Special Issue seeks articles that present novel bioinks, new manufacturing technologies, new bioprinting protocols and designs in the bioprinting field that will lead to physiologically optimized artificial constructs with particular interests in:
- New bioprinting technologies;
- Novel functional, biocompatible material/bioink formulations for bioprinting;
- Bioprinting mathematical modelling and design optimization;
- Bioprinted devices with controlled releasing of active ingredients (drug, growth factors, etc.);
- Multi-material/multi-functional devices for tissue engineering/drug screening;
- Design and application of medical-related new materials;
- Evaluation and analysis of biocompatibility and safety of medical implants by bioprinting;
- 4D bioprinting;
- Recent progress in other bioprinting-related fields.
Prof. Dr. Xiaoxiao Han
Dr. Yinfeng He
Dr. Liyang Shi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioprinting
- biomaterials
- tissue engineering
- controlled release
- 4D printing
